Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

The U.S. Food and Drug Administration has issued a warning about a rare but severe reaction that can happen to people who ...

Two common anti-allergy medications can leave you feeling scratchier than ever. The Food and Drug Administration is warning ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

US FDA accepts for review GSK’s NDA for linerixibat to treat cholestatic pruritus in patients with PBC: London, UK Tuesday, June 3, 2025, 11:00 Hrs [IST] GSK plc announced the U ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the ...

"Pruritus in older people is most often linked to physiological changes in the skin caused by aging, leading to significant xerosis. However, before attributing it to aging, we need to rule out ...